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ARTICLE
Scan-Statistic Approach Identifies Clusters of Rare
Disease Variants in LRP2, a Gene Linked and Associated
with Autism Spectrum Disorders, in Three Datasets
Iuliana Ionita-Laza,1,* Vlad Makarov,2 the ARRA Autism Sequencing Consortium,3
and Joseph D. Buxbaum2,4,5,*
Cluster-detection approaches, commonly used in epidemiology and astronomy, can be applied in the context of genetic sequence data
for the identification of genetic regions significantly enriched with rare disease-risk variants (DRVs). Unlike existing association tests for
sequence data, the goal of cluster-detectionmethods is to localize significant diseasemutation clusters within a gene or region of interest.
Here, we focus on a chromosome 2q replicated linkage region that is associated with autism spectrum disorder (ASD) and that has been
sequenced in three independent datasets. We found that variants in one gene, LRP2, residing on 2q are associated with ASD in two data-
sets (the combined variable-threshold-test p value is 1.2 3 105). Using a cluster-detection method, we show that in the discovery
and replication datasets, variants associated with ASD cluster preponderantly in 25 kb windows (adjusted p values are p1 ¼ 0.003 and
p2 ¼ 0.002), and the two windows are highly overlapping. Furthermore, for the third dataset, a 25 kb region similar to those in the other
two datasets shows significant evidence of enrichment of rare DRVs. The region implicated by all three studies is involved in ligand
binding, suggesting that subtle alterations in either LRP2 expression or LRP2 primary sequence modulate the uptake of LRP2 ligands.
BMP4 is a ligand of particular interest given its role in forebrain development, and modest changes in BMP4 binding, which binds to
LRP2 near the mutation cluster, might subtly affect development and could lead to autism-associated phenotypes.Introduction
Advances in next-generation-sequencing technologies1
facilitate large-scale sequencing studies and allow for
a comprehensive investigation of the role that rare variants
might play in complex diseases with the hope that rare
variants can provide further insight into the underlying
biology of these diseases. Ongoing sequencing studies are
already generating unprecedented amounts of genetic
data. The large number of genetic variants, most of which
have low population frequencies, being uncovered in these
datasets creates particular challenges for the statistical
analysis of this new type of data. Already, many association
tests for sequence data have been proposed.2–13 These
methods are concerned with rejecting the null hypothesis
that variants in a gene or region are not associated with
disease.
The focus in this paper is on the localization of rare
disease-risk variants (DRVs) in a larger genetic region via
a cluster-detection method. Unlike existing association
tests that test for disease association with variants in a con-
tained genetic region, the goal here is to find the window
(within the larger region) in which DRVs cluster more
significantly than they do in the rest of the region, i.e.,
outside of the window. Here, we describe a method that
is specifically designed to identify such small regions en-
riched with DRVs and that is quite different from existing
association tests (more details on the differences between
cluster-detection methods and association tests will be1Department of Biostatistics, Columbia University, New York, NY 10032, USA;
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detectionmethods are commonly used in applied sciences,
such as in epidemiology for the identification of hotspots
of disease cases (i.e., epidemics), as well as in astronomy
for the identification of star clusters and galaxies. One
popular class of methods is based on the use of scan statis-
tics.14 The underlying idea of scan-statistic methodology is
to slide a window of fixed size w along the length of the
region and compute an overall statistic for all windows of
length w. We propose here a likelihood ratio (LR) statistic
that takes into account the underlying spatial distribution
of variants in the population; this LR statistic is similar to
an approach proposed by Kulldorff.15 For each window
Wof size w, we calculate the LR statistic, LRW. The window
W with the highest value for the LRW is the most likely
region to harbor a cluster of DRVs, and an approximate
p value for the window with the largest LRW is calculated
by Monte Carlo simulations.
Clustering of diseasemutations in small regions of a gene
has been reported before for someMendelian diseases and,
more recently, for several complex traits as well. For
example, highly localized mutations in the gene encoding
the cytoskeletal protein filamin A (FLNA [MIM 300017])
lead to a broad range of congenital malformations in
humans.16 Similarly for Duchenne muscular dystrophy
(MIM 310200) and the milder form, Becker muscular
dystrophy (MIM 300376), mutations cluster in actin
binding domain 1 (ABD1) of dystrophin17 (MIM 300377).
Other examples include Rett syndrome18 (MIM 312750),2Seaver Autism Center for Research and Treatment, Mount Sinai School of
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hereditary angioneurotic edema19 (MIM106100), VonWil-
lebrand disease type 2A20 (MIM 613554), etc. For complex
traits, not many of such studies have been published to
date. A recent study focusing on somatic cancer mutations
found that disease-causing mutations cluster more often
than random mutations, suggesting that mutation hot-
spots occur at the domain level.21 Similarly, a study on
schizophrenia (MIM 181500) and bipolar disorder (MIM
125480) identified significant clustering of nonsynony-
mousSNPs in twoexons encoding the cysteine-richdomain
and first transmembrane helix of metabotropic (GRM1)
glutamate receptor.22Here,we report for three independent
datasets a clustering of rare DRVs in a small region of LRP2
(MIM600073), a gene residing in a replicated linkage region
for autism spectrum disorder (ASD [MIM 209850]) on chro-
mosome 2q.23–25
Autism and ASD are associated with high heritability.
There have been successes in identifying chromosomal
abnormalities and copy-number variants that contributeLRW ¼
8<
:
cpWbrG
yW1 cpW
1 brG
nWyWcqWbrG
yGyW1 cqW
1 brG
nGnWðyGyWÞ
if cpW > cqW
1 otherwise
;significantly to risk. These variants are individually rare
but in combination are etiological factors in as much as
15% of ASD. Candidate-gene sequencing studies have
identified many genes associated with high risk, and,
with the advent of whole-exome and whole-genome
sequencing, it is becoming possible to exhaustively explore
the influence of rare variants, both single point and struc-
tural, on the risk of developing ASD.
We apply such a cluster-detection method to three inde-
pendent ASD datasets. We identify LRP2 in an ASD-linked
region on chromosome 2q as being associated with ASD in
two of the datasets. Furthermore, we show that rare risk
variants cluster significantly in affected individuals in
highly overlapping regions for all three datasets.Material and Methods
The underlying idea of scan-statistic methodology is to slide
a window of fixed size w along the length of the region and
compute a statistic Sw. For example, when testing whether points
on a line are uniformly distributed, Sw could be the maximum
number of points along the line in any window of size w. Wallen-
stein and Neff26 derived the approximate distribution for Sw under
the simplified assumption that points are independent and
uniformly distributed across a region. However, it is well known
that genetic-variant positions can cluster in a nonuniform fashion
on the basis of purely biological reasons, and such a clustering
might not be related to disease. Therefore, any reasonable method
needs to take into account the underlying spatial distribution of
variants in the population. Kulldorff15 described a LR statistic,
and we follow a similar approach here.The AmericScan Statistic for the Identification of Clusters
of Rare DRVs
Let us assume that N unrelated individuals, both affected and
unaffected, have been sequenced in a region or gene of interest
G. Furthermore, let us assume that there are M rare-variant posi-
tions in the region of interest. A rare variant is identified as
a variant with a minor allele frequency (MAF) that is less than
a fixed threshold (e.g., 0.01) in controls. At each position i with
i% M, let ni be the number of individuals that carry a rare variant
and let yi be those that are affected. Therefore, yi is binomial (ni, pi),
where pi is related to the relative risk at position i. We are working
under the assumption that there is a window Wdis such that
pi ¼ pWdis for i˛Wdis and pi ¼ p0 for i;Wdis. Under the null
hypothesis, pWdis ¼ p0, whereas the alternative hypothesis is that
pWdis > p0. For a fixed window size, we employ a sliding-window
approach and calculate a LR statistic.
Bernoulli Model
To calculate the LR statistic, we first condition on the window W
and calculate for each window W of fixed size w the following
LR score:where
yW ¼
P
i˛W
yi and yG ¼
P
i˛G
yi;
nW ¼
P
i˛W
ni and nG ¼
P
i˛G
ni;
cpW ¼ yW
nW
and cqW ¼ yG  yW
nG  nW ;
and brG ¼ yG
nG
:
Note that dpW and dqW are the maximum likelihood estimators
(MLEs) under the alternative hypothesis, whereas crG is the MLE
under the null hypothesis. A pseudocount of 1 is added when
the proportions pW, qW, and rG are estimated.
The LR statistic for window size w is then computed as
Lw ¼ maxjW j ¼w LRW :
The window W with the highest value for the LRW is the most
likely region to harbor a cluster of DRVs.
Definition of WindowsW
The definition of the windowsW for consideration is flexible and
depends on the region under investigation, such as its length. The
unbiased, agnostic approach is to consider all contiguous (and
overlapping) windows of a fixed size w. Another possibility is to
define windows on the basis of known biological features, such
as known functional domains. This could be more powerful
than the agnostic approach because it might lead to increased
signal in the windows being tested and also reduced penalty for
multiple-testing correction.
In the agnostic approach, the size of the sliding window, w, is
not known a priori; therefore, we can consider several distinctan Journal of Human Genetics 90, 1002–1013, June 8, 2012 1003
Table 1. Simulated Data
a
Type-1 Error Rates
w ¼ 2 kb w ¼ 5 kb w ¼ 8 kb VW
0.05 0.049 0.061 0.055 0.055
0.01 0.008 0.012 0.014 0.012
Reported in the table are empirical type-1 error rates corresponding to nominal
a levels of 0.05 and 0.01. The size, w, of the sliding window can take three
possible values between 2 and 8 kb. There are 300 cases and 300 controls.
The variable window (VW) approach corresponds to maximizing over windows
of length between 2 and 8 kb.window sizes and evaluate the overall significance by permuta-
tion. More precisely, we can define the generalized LR statistic as
the following:
GLR ¼ max
w
max
jW j ¼w
LRW :
We call this the variable window (VW) approach because multiple
window sizes are considered. The maximum window size consid-
ered is, at most, 50% of the total region length.
Statistical Significance
For the purposes of inference, we compute the above LRW statistics
for all windowsW that we choose to consider. LetLw ¼ max
W
LRW .
Standard asymptotic-theory results do not apply here (1)
because of the implicit assumption of independence among
different rare variants in the likelihood calculation and (2) because
the parameter Wdis disappears under the null hypothesis and is
only present under the alternative.27 Therefore, we use Monte
Carlo simulations to compute the p value for Lw. We permute
the affection-status labels and then recalculate the maximum LR
statistic across all windows as was done for the original study. A
similar permutation procedure is performed for the VWapproach,
whichmaximizes overmultiple window sizes. Note that the result-
ing p values are adjusted for multiple testing (i.e., for all overlap-
ping windows that are being considered).Table 2. Simulated Data
Gene
Length
(kb)
Cluster
Length
(kb) % DRVs
Power
w ¼ 2 kb w ¼ 5 kb w ¼ 8 kb VW
10 2.4 20% 0.77 0.59 0.28 0.73
10 4.8 20% 0.37 0.47 0.31 0.49
20 4.8 20% 0.84 0.96 0.85 0.95
20 9.5 20% 0.52 0.70 0.80 0.64
Power is at a ¼ 0.05. There are 300 cases and 300 controls. Gene length refers
to the length of the gene, and cluster length refers to the length of the cluster
of DRVs. Power is averaged over randomly selected genes of fixed length. 20%
of variants in a gene are assumed to be DRVs.Results
Simulated Data
Type-1 Error and Power
We use simulations to investigate the underlying proper-
ties of the proposed approaches. We simulated one 1 Mb
genomic region under a coalescent model by using the
software package COSI.28 The model used in the simula-
tion was the calibrated model for the European population
and was an option available in the COSI package (the best-
fit model). A total of 10,000 haplotypes were generated.We
then randomly sampled small regions of the size of indi-
vidual genes (between 1.5 and 200 kb).
To evaluate the type-1 error, we derived datasets of 300
cases and 300 controls under the null hypothesis of no
association between any of the variants and disease.
To evaluate the power of the approach, we assume that
a subregion is enriched with rare DRVs. The percentage
of DRVs in a simulated gene is assumed to be 20% for genes
of length 10 kb and 20 kb and 3%–10% for larger
genes (i.e., 50–200 kb). We have also considered smaller
genes of sizes 1.5 kb and 3 kb and assumed that 20%–
50% of variants are DRVs. DRVs are chosen to be variants
that have a frequency less than 0.01 and that reside in
a small subregion of the gene. Assuming D DRVs, then
dichotomous phenotypes are simulated from
logit Pðy ¼ 1Þ ¼ b0 þ
XD
j¼1
bjXj;
where b0 ¼ logitð0:05Þ. We can specify the effect size at
each DRV by setting bj ¼ cjlog10ðMAFjÞj for the jth disease
variant. We take c ¼ 0.549, which results in an odds ratio
(OR) of 9 for variants with MAF ¼ 104 and an OR of 5.21004 The American Journal of Human Genetics 90, 1002–1013, Junefor variants with MAF ¼ 103. For a large 200 kb gene,
we take c¼ 0.400, which results in an OR of 4.9 for variants
with MAF ¼ 104 and an OR of 3.3 for variants with
MAF ¼ 103.
Type-1 Error. In Table 1, we report the empirical type-1
error for the clustering approach described above when it is
applied to data simulated under the null hypothesis of no
association between any of the variants in the region and
disease. Different window sizes are considered between 2
and 8 kb. As shown, the empirical type-1 error agrees
well with the nominal one.
Power. In Table 2, we report power estimates by using
simulated data. Power is averaged over randomly chosen
regions with lengths between 10 and 20 kb. Similar
results are shown in Table A1 for regions of larger size,
i.e., 50–200 kb.
The power of the cluster-detection approach depends
critically on the length of the cluster window. As shown
in Table 2, the power decreases when the size of the cluster
window increases relative to the entire region. This is ex-
pected because the larger the size of the cluster, the weaker
the evidence that DRVs cluster in any particular small
region. The size of the scanning window is also important,
and the power can vary dramatically depending on that.
In particular, the power decreases substantially when the
scanning window is too large. Intuitively, the optimal
size is the cluster’s true size, which is unknown to us.
Therefore, we have proposed maximizing over multiple
window sizes (the VW approach), an approach which
compares well to the optimal power, as we show in simula-
tions (Tables 2, A1, and A3).8, 2012
Table 3. Simulated Data
Gene
Length
(kb)
Cluster
Length
(kb) % DRVs
Jaccard Index of Overlap
w ¼ 2 kb w ¼ 5 kb w ¼ 8 kb VW
10 2.4 20% 0.69 0.41 0.22 0.66
10 4.8 20% 0.35 0.74 0.49 0.60
20 4.8 20% 0.37 0.83 0.57 0.75
20 9.5 20% 0.19 0.47 0.72 0.54
Shown is the overlap between the true cluster region and the estimated cluster
region as measured by the Jaccard index of overlap. There are 300 cases and
300 controls. Gene length refers to the length of the gene, and cluster length
refers to the length of the cluster of DRVs. The index of overlap is averaged over
randomly selected genes of fixed length. 20% of variants in a gene are assumed
to be DRVs.Power will generally be low for geneswith little variation,
as might be the case with small genes. We have looked at
genes of sizes 1.5 kb and 3 kb and show that power can be
quite low even if a large percentage (50%) of variants are
in fact disease related (Table A3). In such cases, the clus-
teringproblembecomes less interestingbecauseof the small
number of observed variants in such small genes, and
a simple gene-based association test will be more powerful.
Estimation of Cluster Location
Another important measure of performance for the
proposedmethod is the overlap between the true simulated
cluster region (T) and the estimated cluster region (E),
namely the window with the maximum LR score. One
natural measure of overlap between two regions T and E is
the Jaccard index of overlap, defined as the size of the inter-
section divided by the size of the union of the two regions:
JðT ;EÞ ¼ jTXE jjTWE j :
If the two regions are disjoint, then JðT ;EÞ ¼ 0, and if the
two regions coincide, then JðT ;EÞ ¼ 1.
In Table 3, we report the overlap between the true and
estimated cluster regions for the same scenarios for which
power was reported in Table 2 (also see Tables A2 and A4).
As with power, the highest overlap is achieved when the
scanning-window size is close to the true cluster size. We
also note that, as with power, the VW approach results in
good overlap with the true region (values for the Jaccard
index of overlap are over 0.50 in the simulated scenarios).
Clustering Versus Self-Contained Tests
Such a cluster-detection approach is ideal in situations in
which multiple DRVs cluster in a small window of
a gene. An alternative statistic for each window would be
any of the sequence-based association statistics (e.g.,
burden statistics) already proposed in the literature
comparing affected and unaffected individuals sequenced
in a region of interest. The latter test is called a self-con-
tained test in that, unlike the proposed procedure, it does
not compare the association signal in a window with the
association signal that is outside.
The two types of tests are designed for different goals. In
particular, the null hypotheses for the two tests areThe Americdifferent. For the proposed test, the null hypothesis is that
the DRVs are distributed as expected on the basis of the
spatial distribution of variants in the population for that
gene, whereas for the self-contained test, the null hypoth-
esis is that there is no association between any of the vari-
ants in the gene and disease. If the latter is true, i.e., no asso-
ciation, then the former is true too, i.e., no clustering. The
converse, however, is not true. It is possible that variants
associated with disease do not cluster. It is only the
proposed test that can identify significant clustering of
rareDRVs, whereas the self-contained test can only identify
significant association in awindow, but that does not imply
there is significant clustering of rare DRVs in that window.
Another important difference between the two methods
is in the precision of estimation of cluster boundaries. We
have compared the proposed clustering approach with two
self-contained tests by using simulated data. We have
simulated a gene of size 20 kb and assumed that 20% of
all the variants in the gene are DRVs; 66% of DRVs cluster
in a 3.5 kb window, whereas the rest are uniformly distrib-
uted. We then used a scanning window of size w ¼ 4 kb,
and for each such window, we calculated three statistics:
(1) the log(LR) statistic proposed here, (2) the Z score
from the burden test, and (3) the p value from the
collapsing method,2 all of which are restricted to variants
with MAF % 0.01. We show in Figure 1 that the clus-
tering-based approach correctly identifies the true cluster
window of size 3.5 kb, whereas the burden test and the
collapsing test lead to noisier results (more results are
shown in the Supplemental Data). Furthermore, it is not
clear from the results of the burden or collapsing tests
whether there is significant clustering or not; this is natu-
rally so given that such self-contained tests are designed
to test for association and not clustering.
Application to ASD
Discovery Dataset
For the discovery stage, we have used sequence data gener-
ated in Faham et al.29 In that study, the authors sequenced
(by using mismatch-repair detection on tag arrays) approx-
imately 397 ASD patients and 450 controls; they mostly
targeted coding regions of 68 genes within a 20 Mb chro-
mosome 2q linkage peak that has been implicated in
ASD by multiple whole-genome linkage scans.
First, we applied the variable threshold (VT) association
test4 and tested each of the 68 genes in the linked region
on chromosome 2q. By using the VT method and maxi-
mizing over several MAF thresholds between 0.01 and
0.50, two genes, namely LRP2 (p ¼ 7.4 3 105) and
CMYA3 (p ¼ 105 [MIM 609778]) are region-wide signifi-
cant (Figure 2). The p values for LRP2 and CMYA3 were
calculated with several MAF thresholds (Table A5).
LRP2 is a long gene (~235 kb), and we have performed
a clustering analysis to investigate whether rare DRVs
cluster preponderantly in a small window of the gene. We
have calculated the LR statistic for all overlapping windows
of lengths between 5 and 30 kb and have identified onean Journal of Human Genetics 90, 1002–1013, June 8, 2012 1005
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Figure 1. Clustering Versus Self-Con-
tained Tests
Precision of estimation of the cluster
boundaries for a simulated cluster region.
A 20 kb gene is simulated with DRVs clus-
tered in a 3.5 kb window at the start of the
gene. From top to bottom, the graphs
depict a cluster test, a burden test, and
a collapsing test.25 kbwindow (170,072,764 –170,097,764; hg19) that is en-
riched with rare risk variants (the p value adjusted for all
25 kb windows is 0.003; Figure 3). The p values for other
window sizes are shown in Table 4. The p value adjusted
for testing all windows with lengths between 5 and 30 kb
is 0.01. The variant amplicons in this window, togetherGene-based p Values (VT), Chromosome 2q
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Figure 2. Empirical p Values for 68 Genes Sequenced in the
Linked Region on Chromosome 2q29
Two genes, namely LRP2 and CMYA3, remain significant after
multiple-testing correction.
1006 The American Journal of Human Genetics 90, 1002–1013, June 8, 2012with observed frequency counts in
cases and controls, are shown in Table
A6. Note that for the clustering
analysis, variant amplicons with a
frequency less than 0.10 in controls
were included in the analysis. With
a frequency threshold of 0.01, the
same peak region is identified, and
the p value (adjusted for all windows
with sizes between 5 and 30 kb) is
0.054, whereas for a frequency
threshold of 0.05, the p value is 0.040.
LRP2 is a member of the low density
lipoprotein receptor (LDLR [MIM
606945]) gene family, and, like LDLR,
LRP2 can bind ApoE as well as a large
variety of additional ligands. The
expression of LRP2 in the brain and
the functional importance of some
LRP2 ligands have indicated that
LRP2 plays a role in neuronal develop-ment and regeneration.30 Recently, a de novo deleterious
mutation in LRP2 was found by whole-exome sequencing
in one ASD case.31 Defects in LRP2 are known to cause Don-
nai-Barrow (aka, facio-oculo-acoustico-renal) syndrome,32
a rare neurological disease. Furthermore, mutations in
LRP2 have been shown to disrupt cortical development in
mice.33 LRP2 is also known to play a role in brain develop-
ment,34 including forebrain development, through its
effects on sonic hedgehog (Shh) signaling.35 Specifically,
LRP2 binds BMP4, leading to its internalization and catabo-
lism, and reduced levels of LRP2 are associatedwith elevated
BMP4 and disruption of normal brain development.35,36
Also, LRP2 has been shown to be an auxiliary receptor
for Sonic hedgehog by regulating the tracking of the SHH/
PTCH1 complex.37 Gene-dosage abnormalities at PTCH1
lead to a syndrome that includes developmental delay
and/or intellectual disability, as well as occasionally autism
along with other features.38, 39, 40 In van der Zwaag et al.41
the authors used knowledge on functional gene networks
to perform a topology-corrected Prioritizer analysis42 and
report the top ten genes out of 109 genes in the 2q linked
region. LRP2 ranks first among these 109 genes with a
p value of 0.007.
The cluster window maps to a region that includes four
tandem epidermal growth factor (EGF) precursor homo-
logy domains, particularly the two most NH-terminal
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Figure 3. Clustering of Rare DRVs in LRP2 for Three Datasets
For each window, the midpoint is plotted on the x axis. The 25 kb
windows with maximum LR score are also shown for the three
datasets. Scanning-window length is w ¼ 25 kb.domains. This is just downstream of the domain that binds
RAP, and the fact that there is evidence that BMP4 and RAP
share binding sites in LRP235 suggests that alterations in
the interaction of LRP2 with BMP4 caused by various
mechanisms, including changes in protein levels or
primary amino acid sequence, can lead to subtle changes
in forebrain development, an area of great importance in
autism-related phenotypes.
The original Faham et al.29 study concentrated on more
common variants and only reported the association with
variants in CMYA3, although an independent replication
attempt failed at that time. There are only 13 variants
observed in this gene, which makes a clustering analysis
for this gene not meaningful.
Replication Datasets
We have used an independent dataset to replicate the
finding on the risk-variant cluster within LRP2. Hence, we
have applied the cluster-detection approach to a second da-
taset (ARRA-Broad; see Appendix A for more information)
consisting of 430 cases and 379 controls sequenced in the
exonic regions of LRP2. We have identified a 25 kb window
of significant clustering resulting in a p value (adjusted for
all 25 kb windows) of 0.038, and the window with the
maximum LR statistic is 170,068,479–170,093,479. If
only nonsynonymous variants are considered, the adjusted
p value for all 25 kb windows is 0.02 and the p valueTable 4. LRP2 Results
Dataset
p Value
w ¼ 5 kb w ¼ 10 kb w ¼
Discovery 0.019 0.007 0.00
ARRA-Broad 0.134 0.070 0.03
ARRA-Broad-NS 0.151 0.080 0.01
Shown are p values for the LR statistic ðLw ¼maxjWj¼wLRW Þwhen window sizew i
(ARRA-Broad) are considered. VW corresponds to the variable-window approach o
abbreviation is used: NS, nonsynonymous only.
The Americadjusted for all overlappingwindows with lengths between
5 and 30 kb is 0.01 (Table 4). The variants in this window,
together with functional annotations and observed
frequency counts in cases and controls, are shown in Table
A7. Note that this window overlaps substantially with the
window detected in the discovery dataset (i.e.,
170,072,764–170,097,764; the Jaccard index of overlap is
0.71). In Figure 3, we plot for each window W of size 25
kb the corresponding logðLRWÞ values for the two datasets.
There is substantial overlap between the windows of
maximumLR score in the two datasets, although the signal
is, as expected, stronger in the discovery dataset than in the
replication dataset. Also, because of the smaller number of
variants in the discovery dataset, the peak for the discovery
dataset is also broader in that case.
If we perform an overall test of association at the gene
level, variants in LRP2 are significantly associated with
ASD (VT-test p value of 0.011). The combined VT-test
p value based on the two datasets is 1.23 105. Restriction
to only nonsynonymous variants did not result in signifi-
cant results (probably as a result of the ensuing exclusion
of common variants, some of which are associated with
ASD as we show below). Also, there is no evidence of asso-
ciation in this dataset with variants in CMYA3.
Common Variant Analysis in LRP2. We have also tested
for associationbetween the commonvariants inLRP2 (MAF
R 0.05) and ASD by using the software package PLINK. Of
32variantswithMAFR0.05, tenof themhave pvalues (Co-
chran-Armitage test) less than 0.05 (although they are not
all independent signals), and all of them are in the same
direction (Table A8). Compared with the unassociated vari-
ants, these associated variants are substantially closer to the
enriched window above; all of the ten associated variants
are within 10 kb of the 25 kb window identified above. In
addition, we have performed a gene-based test in PLINK
for the common variants, and the p value is 0.03.
Second Replication Dataset. Wehave used a second repli-
cation dataset (ARRA-Baylor; see Appendix A for more
information) consisting of 502 cases and 489 controls.
When the scanning window size w is 25 kb (as above), we
find that the window of maximum LR score is
170,063,380–170,088,380, which again highly overlaps
with the cluster windows in the previous two datasets
(Figure 3). The p values for enrichment in this window
compared with that in the rest of the gene are 0.015 (for20 kb w ¼ 25 kb w ¼ 30 kb VW
5 0.003 0.002 0.010
5 0.038 0.200 0.099
1 0.002 0.008 0.010
s between 5 and 30 kb, and variants with MAF f% 0.1 (Discovery) and f% 0.01
f maximizing over multiple window sizes between 5 and 30 kb. The following
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all variants) and 0.010 (for nonsynonymous variants only).
Although these p values are specific to that window and do
not survive correction for multiple testing for all overlap-
ping 25 kb windows (as was the case for the previous two
datasets), the evidence of significant clustering in the
same region adds to the evidence from the first two data-
sets. Results remain significant (p < 0.05) if other window
sizes (between 5 and 30 kb) are considered as well.
Randomized Sampling. To showmore evidence that the
observed cluster windows in the three datasets are likely to
represent bona fide regions enriched with rare DRVs, we
have performed simple randomization experiments. In
one example, cases and controls were randomly mixed
and the cluster-detection method was then applied to the
resulting datasets. As shown in Figure A1, the results are
consistent with the null model of no clustering. In partic-
ular, the windows in which the maximum LR score is
achieved for the threedatasets are all disjoint. Similar results
holdwhen cases and controls are completely interchanged.
Discussion
By using a scan-statistic approach, we have identified clus-
ters of rare DRVs in LRP2, which resides in a replicated ASD
linkage region within chromosomal region 2q31.1 and
which we have also shown to be associated with ASD on
the basis of two independent datasets. Our applications
to three independent ASD datasets revealed three highly
overlapping 25 kb LRP2 regions that are more significantly
enriched with rare DRVs than is the rest of the gene.
Such a cluster-detection approach is ideal in cases where
multiple rare DRVs cluster in a small region of a gene.
When the gene under consideration is large, as is the case
with LRP2, replication of association signals at the gene
level can be challenging, and identification of such overlap-
ping cluster regions can be important evidence of replicable
signal. Furthermore, identifying such a cluster of genetic
risk factors, when it exists, is important because it might
provide insights into the underlying biological mechanism
for the disease. The cluster region identified in our studies is
involved in ligand binding. Onemechanism that is consis-
tent with the results is that subtle alterations in either LRP2
expression or LRP2 primary sequence modulate the uptake
of LRP2 ligands. BMP4 is a ligandof particular interest givenTable A1. Simulated Data for Large Genes
Gene Length (kb) Cluster Length (kb) % DRVs
Powe
w ¼ 5
50 2.9 5% 0.92
50 6.0 10% 1.00
200 22 3% 0.66
200 25 5% 0.85
Power is at a ¼ 0.05. There are 300 cases and 300 controls. Gene length refers to
DRVs. Power is averaged over randomly selected genes of fixed length. 3% – 10%
used: DRV, disease risk variant; w, window size; and VW, variable-window approa
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been shown to lead to excess levels of BMP4 and disrupted
development of the prosencephalon. Evenmodest changes
in BMP4 binding might subtly affect development and
could lead to autism-associated phenotypes.
Some of the problems that affect association tests in
general are also relevant for the cluster method discussed
here. Like the burden tests of association, the proposed
method assumes that the effects of variants are all in the
same direction. In some cases, it is possible that a mixture
of risk and protective variants is present in a region, espe-
cially if the region under consideration is large. Although it
is probably less likely for this scenario to happen in a small
cluster regionthatmight correspondtoa functionaldomain,
when this happens, the power for identifying a cluster will
decrease. Population stratification is also a potential concern
for the proposedmethod.However, because the enrichment
of rare disease variants in a window is contrasted with that
outside of the window, the stratification would generate
a clustering effect only if a small portion of the larger region
were to be affected by population stratification.
The proposed cluster-detection method is designed
specifically to identify small windows (within a larger
region) that have significantly more rare DRVs than the
rest of the region. As such, it is very different from existing
association tests that test for associationbetweenvariants in
a contained genetic region and disease and which cannot,
by definition, implicate clustering of rare disease variants
in any part of the region under consideration. Therefore,
the proposed method complements existing region-based
association tests and can be useful in identifying the parts
of a gene or region that are involved in disease etiology.
Appendix A: Data Generation and Processing
for the AASC Data
The replication datasets have been sequenced as part of the
ARRA Autism Sequencing Collaboration. Whole-exome
sequencing of the samples was carried out at the Broad
Institute and at the Baylor College of Medicine via stan-
dard approaches.
Sequence-data processing and variant calling were per-
formed with similar workflows at both sites. Data were pro-
cessed with Picard43 (see Web Resources) and BWA44 forr
kb w ¼ 10 kb w ¼ 20 kb w ¼ 30 kb VW
0.68 0.35  0.95
0.97 0.80  0.99
 0.68 0.63 0.63
 0.99 0.95 0.90
the length of the gene, and cluster length refers to the length of the cluster of
of variants in a gene are assumed to be DRVs. The following abbreviations are
ch.
8, 2012
Table A2. Simulated Data for Large Genes
Gene Length (kb) Cluster Length (kb) % DRVs
Jaccard Index of Overlap
w ¼ 5 kb w ¼ 10 kb w ¼ 20 kb w ¼ 30 kb VW
50 2.9 5% 0.57 0.23 0.09  0.49
50 6.0 10% 0.69 0.55 0.28  0.68
200 22 3% 0.18  0.59 0.58 0.55
200 25 5% 0.17  0.72 0.63 0.72
Shown is the overlap between the true cluster region and the estimated cluster region as measured by the Jaccard index of overlap. There are 300 cases and 300
controls. Gene length refers to the length of the gene, and cluster length refers to the length of the cluster of DRVs. The index of overlap is averaged over randomly
selected genes of fixed length. 3% – 10% of variants in a gene are assumed to be DRVs. The following abbreviations are used: DRV, disease risk variant; w, window
size; and VW, variable-window approach.
Table A3. Simulated Data for Small Genes
Gene Length (kb) Cluster Length (kb) % DRVs
Power
w ¼ 0.2 kb w ¼ 0.5 kb w ¼ 0.8 kb w ¼ 1.0 kb w ¼ 1.5 kb VW
3.0 0.7 20%  0.22  0.42 0.25 0.46
3.0 1.7 50%  0.08  0.32 0.26 0.26
1.5 0.3 20% 0.28 0.30 0.20   0.14
1.5 0.8 50% 0.14 0.15 0.32   0.15
Power is at a ¼ 0.05. There are 300 cases and 300 controls. Gene length refers to the length of the gene, and cluster length refers to the length of the cluster of
DRVs. Power is averaged over randomly selected genes of fixed length. 20% – 50% of variants in a gene are assumed to be DRVs. The following abbreviations are
used: DRV, disease risk variant; w, window size; and VW, variable-window approach.
Table A4. Simulated Data for Small Genes
Gene Length (kb) Cluster Length (kb) % DRVs
Jaccard Index of Overlap
w ¼ 0.2 kb w ¼ 0.5 kb w ¼ 0.8 kb w ¼ 1.0 kb w ¼ 1.5 kb VW
3.0 0.7 20%  0.41  0.46 0.32 0.48
3.0 1.7 50%  0.25  0.44 0.61 0.55
1.5 0.3 20% 0.31 0.29 0.20   0.32
1.5 0.8 50% 0.20 0.47 0.49   0.37
Shown is the overlap between the true cluster region and the estimated cluster region as measured by the Jaccard index of overlap. There are 300 cases and 300
controls. Gene length refers to the length of the gene, and cluster length refers to the length of the cluster of DRVs. The index of overlap is averaged over randomly
selected genes of fixed length. 20% – 50% of variants in a gene are assumed to be DRVs. The following abbreviations are used: DRV, disease risk variant;w, window
size; and VW, variable-window approach.
Table A5. Discovery Dataset
Gene
p Value
MAF 0.01 MAF 0.10 VT
LRP2 1.2 3 102 4.4 3 104 7.4 3 105
CMYA3 3.8 3 101 8.0 3 102 1.0 3 105
LRP2 and CMYA3 p values calculated with minor allele frequency (MAF) %
{0.01, 0.10} and with the variable threshold (VT) approach maximizing over
multiple MAF thresholds.
Table A6. LRP2 Variants in the 25 kb Window of Maximum LRW
from the Discovery Dataset
Position Amplicon Length Gene fA fU
170,072,764 259 LRP2 0.005 0.000
170,076,965 198 LRP2 0.006 0.000
170,081,821 219 LRP2 0.001 0.000
170,082,933 257 LRP2 0.009 0.007
170,088,225 199 LRP2 0.093 0.115
170,089,922 258 LRP2 0.020 0.006
170,094,602 274 LRP2 0.003 0.005
170,097,689 258 LRP2 0.026 0.011
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Table A7. LRP2 Variants in the 25 kb Window of Maximum LRW from the ARRA Broad Study
Position ID fA fU refAA varAA Function
170,068,479  0.0011 0 Gln Gln silent
170,068,502 rs146149181 0.0023 0 Thr Ser missense
170,068,598 rs138269726 0.0046 0 Asp Asn missense
170,068,628 rs142266106 0 0.0013 Ala Thr missense
170,068,709  0.0011 0 Glu Lys missense
170,068,710 rs144449508 0.0034 0.0013 Ala Ala silent
170,068,713 rs34834388 0.039 0.025 Ala Ala silent
170,070,172 rs4667596 0.017 0.022 Arg Lys missense
170,070,225  0.0011 0 Lys Lys silent
170,070,275  0.0011 0 Glu Gln missense
170,070,348 rs11886219 0.051 0.050 Arg Arg silent
170,070,365 rs41268689 0.0011 0 Val Met missense
170,072,797  0.0011 0 Gln Arg missense
170,077,014  0 0.0013 Thr Thr silent
170,082,013 rs2075246 0.43 0.38   
170,082,936 rs138070797 0.0069 0.0013 Asn Ser missense
170,088,351 rs2302694 0.104 0.106 Ser Ser silent
170,089,934 rs145384264 0.020 0.011 Ser Ser silent
170,090,040  0.0011 0 Arg His missense
170,090,041  0.0011 0 Arg Cys missense
170,090,105  0 0.0013   
170,090,139 rs78750385 0.0069 0.0065   
170,092,386  0 0.0013 Asn Lys missense
170,092,395 rs2229267 0.26 0.21 Cys Cys silent
170,092,439 rs151079411 0.0023 0.0013 Leu Leu silent
170,092,467 rs141068435 0 0.0013 Cys Cys silent
170,092,504  0.0011 0 Arg His missense
170,092,613 rs74457112 0.0011 0   
Table A8. p Values from the Cochran-Armitage Trend Test for the Common LRP2 Variants Significantlya Associated with ASD
Chr Position fA fU p Trend OR
2 170,103,351 0.49 0.41 0.0007 1.40
2 170,099,895 0.49 0.42 0.0037 1.33
2 170,099,473 0.48 0.41 0.0040 1.33
2 170,099,899 0.48 0.41 0.0044 1.33
2 170,099,446 0.48 0.41 0.0045 1.33
2 170,103,336 0.48 0.41 0.0045 1.33
2 170,092,395 0.26 0.21 0.0084 1.33
2 170,096,018 0.33 0.27 0.011 1.31
2 170,115,588 0.49 0.43 0.014 1.27
2 170,066,022 0.20 0.17 0.045 1.29
The following abbreviations are used: Chr, chromosome; and OR, odds ratio.
ap < 0.05.
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Figure A1. Clustering of Rare DRVs in LRP2 for Three Datasets
(A) Cases versus controls.
(B) Random mix of cases and controls.
(C) Controls versus cases.
Scanning window length is w ¼ 25 kb. The 25 kb windows with maximum LR score are also shown for the three datasets.mapping reads to hg19. Variants were called with the use
of several approaches (including the Genome Analysis
Toolkit45 and Atlas-SNP46), and only those variants that
passed standard quality-control filters were analyzed.Supplemental Data
Supplemental Data include 40 figures and a full list of ARRA
Autism Sequencing Consortium authors and affiliations and can
be found with this article online at http://www.cell.com/AJHG.
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